Netarsudil + latanoprost (Roclanda)

Status:
Do Not Prescribe (DNP)
Decision Date:
August 2023
 

Comments

Reduction of elevated intraocular pressure (IOP) in adults with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient IOP reduction. Await national guidance. 

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app